IndraLab

Statements


NS1643 inhibits KCNH2. 3 / 3
| 3

reach
"Binding of NS1643 to the central cavity site appears to mediate pharmacologic block of hERG1 XREF_BIBR."

reach
"12 Surprisingly, results from the present study demonstrate that prolonged stimulation of hERG1 channel in the ER negative breast cancer SKBr3 cells treated with NS1643 arrested the cells in the G0/G1 phase."

reach
"NS1643 reduces the rectification of hERG through fast channel inactivation, thus slowing the onset of hERG inactivation."